Form 4: HealthStream CFO's Equity Transactions Post RSU Vesting
Insider Transaction Report
HealthStream's CFO, Scott Alexander Roberts, reported the vesting of restricted share units and subsequent share transactions, including tax-related dispositions.
Summary
- Scott Alexander Roberts, CFO and SVP of HealthStream Inc. (HSTM), reported transactions on February 27, 2026, related to his beneficial ownership.
- Acquired 2,541 shares of common stock upon the vesting of restricted share units (RSUs) at a price of $0.
- Disposed of 754 shares of common stock at $22.09 per share to cover tax liabilities related to the RSU vesting.
- Following these transactions, Roberts directly owns 32,563 shares of common stock.
- The vesting events included 2,000 RSUs and 541 RSUs, both contingent on continued service and achievement of performance criteria for the period January 1, 2025, through December 31, 2025.
- Performance criteria for the 2025 period were achieved, leading to the vesting of 20% of one RSU award (2,000 units) and 15% of another RSU award (541 units).
- Remaining unvested derivative securities include 4,500 and 3,065 restricted share units.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as the achievement of performance criteria for RSU vesting indicates the company met its internal targets for the specified period, reflecting positively on operational execution.
Positives
- Performance criteria for the January 1, 2025, through December 31, 2025, period were achieved, leading to the vesting of a portion of the restricted share units.
- The vesting of RSUs indicates continued alignment of management incentives with company performance.
Negatives
- A portion of the vested shares (754 shares) was immediately sold to cover tax liabilities, which is a common practice but represents a reduction in direct ownership.
Future Outlook
The vesting schedule for restricted share units extends through February 2030, contingent on continued service and the annual achievement of performance criteria set by the Compensation Committee.
Industry Context
StockSavvy.ai notes that the regular vesting of executive restricted share units and subsequent tax-related sales are standard practices in executive compensation across various industries, including healthcare technology, reflecting performance-based incentives.
Stakeholder Impact
- Shareholders: The vesting and subsequent tax-related sale by a key executive can be seen as a routine event, but the achievement of performance criteria for vesting is a positive indicator of management's execution.
- Employees: The RSU program incentivizes long-term performance and retention of key executives.
Next Steps
- Future vesting of remaining restricted share units on various dates through February 2030, contingent on continued service and achievement of annual performance criteria.
- Annual establishment of performance criteria by the Compensation Committee of the Board of Directors.
Key Dates
| Date | Description |
|---|---|
| 2023-01-01 | Start of performance period for a portion of RSUs. |
| 2023-12-31 | End of performance period for a portion of RSUs. |
| 2024-01-01 | Start of performance period for a portion of RSUs. |
| 2024-02-23 | Vesting date for 15% of certain RSUs for the 2023 performance period. |
| 2024-12-31 | End of performance period for a portion of RSUs. |
| 2025-01-01 | Start of performance period for a portion of RSUs. |
| 2025-02-23 | Vesting date for 20% of certain RSUs for the 2024 performance period. |
| 2025-12-31 | End of performance period for a portion of RSUs. |
| 2026-01-01 | Start of performance period for a portion of RSUs. |
| 2026-02-23 | Vesting date for 20% of 2,000 RSUs for the 2025 performance period, as performance criteria were achieved. |
| 2026-02-27 | Transaction date for acquisition and disposition of common stock, and vesting date for 15% of 541 RSUs for the 2025 performance period, as performance criteria were achieved. |
| 2026-02-27 | Date of filing of the Statement of Changes in Beneficial Ownership. |
| 2026-12-31 | End of performance period for a portion of RSUs. |
| 2027-02-23 | Vesting date for 20% of certain RSUs for the 2026 performance period. |
| 2027-02-27 | Vesting date for 20% of certain RSUs for the 2026 performance period. |
| 2027-01-01 | Start of performance period for a portion of RSUs. |
| 2027-12-31 | End of performance period for a portion of RSUs. |
| 2028-02-23 | Vesting date for 25% of certain RSUs for the 2027 performance period. |
| 2028-02-27 | Vesting date for 20% of certain RSUs for the 2027 performance period. |
| 2029-02-27 | Vesting date for 20% of certain RSUs for the 2028 performance period. |
| 2030-02-27 | Vesting date for 25% of certain RSUs for the 2029 performance period. |
Recommendation
holdThis Form 4 filing details routine executive compensation events, specifically the vesting of restricted share units and a subsequent sale to cover tax obligations. While the achievement of performance criteria for vesting is a positive sign of internal goal attainment, these transactions are generally pre-scheduled and do not typically indicate a change in the company's fundamental outlook or warrant a strong buy/sell recommendation based solely on this filing. It's a neutral event for immediate investment decisions.
Keywords
HealthStream, HSTM, Scott Alexander Roberts, CFO, SVP, SEC Form 4, Insider Trading, Restricted Share Units, RSU Vesting, Equity Compensation, Share Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.